Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Chromatin Profiles of Chromosomally Integrated Human Herpesvirus-6A.

Saviola AJ, Zimmermann C, Mariani MP, Signorelli SA, Gerrard DL, Boyd JR, Wight DJ, Morissette G, Gravel A, Dubuc I, Flamand L, Kaufer BB, Frietze S.

Front Microbiol. 2019 Jun 26;10:1408. doi: 10.3389/fmicb.2019.01408. eCollection 2019.

2.

Higher order genomic organization and epigenetic control maintain cellular identity and prevent breast cancer.

Fritz AJ, Gillis NE, Gerrard DL, Rodriguez PD, Hong D, Rose JT, Ghule PN, Bolf EL, Gordon JA, Tye CE, Boyd JR, Tracy KM, Nickerson JA, van Wijnen AJ, Imbalzano AN, Heath JL, Frietze SE, Zaidi SK, Carr FE, Lian JB, Stein JL, Stein GS.

Genes Chromosomes Cancer. 2019 Jul;58(7):484-499. doi: 10.1002/gcc.22731. Epub 2019 Mar 15. Review.

PMID:
30873710
3.

RUNX1-dependent mechanisms in biological control and dysregulation in cancer.

Hong D, Fritz AJ, Gordon JA, Tye CE, Boyd JR, Tracy KM, Frietze SE, Carr FE, Nickerson JA, Van Wijnen AJ, Imbalzano AN, Zaidi SK, Lian JB, Stein JL, Stein GS.

J Cell Physiol. 2019 Jun;234(6):8597-8609. doi: 10.1002/jcp.27841. Epub 2018 Dec 4. Review.

PMID:
30515788
4.

Regulation of osteogenesis by long noncoding RNAs: An epigenetic mechanism contributing to bone formation.

Tye CE, Boyd JR, Page NA, Falcone MM, Stein JL, Stein GS, Lian JB.

Connect Tissue Res. 2018 Dec;59(sup1):35-41. doi: 10.1080/03008207.2017.1412432.

PMID:
29745821
5.

Higher order genomic organization and regulatory compartmentalization for cell cycle control at the G1/S-phase transition.

Ghule PN, Seward DJ, Fritz AJ, Boyd JR, van Wijnen AJ, Lian JB, Stein JL, Stein GS.

J Cell Physiol. 2018 Oct;233(10):6406-6413. doi: 10.1002/jcp.26741. Epub 2018 May 10. Review.

PMID:
29744889
6.

Bivalent Epigenetic Control of Oncofetal Gene Expression in Cancer.

Zaidi SK, Frietze SE, Gordon JA, Heath JL, Messier T, Hong D, Boyd JR, Kang M, Imbalzano AN, Lian JB, Stein JL, Stein GS.

Mol Cell Biol. 2017 Nov 13;37(23). pii: e00352-17. doi: 10.1128/MCB.00352-17. Print 2017 Dec 1. Review.

7.

Intranuclear and higher-order chromatin organization of the major histone gene cluster in breast cancer.

Fritz AJ, Ghule PN, Boyd JR, Tye CE, Page NA, Hong D, Shirley DJ, Weinheimer AS, Barutcu AR, Gerrard DL, Frietze S, van Wijnen AJ, Zaidi SK, Imbalzano AN, Lian JB, Stein JL, Stein GS.

J Cell Physiol. 2018 Feb;233(2):1278-1290. doi: 10.1002/jcp.25996. Epub 2017 Jun 22.

8.

Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL.

Schjerven H, Ayongaba EF, Aghajanirefah A, McLaughlin J, Cheng D, Geng H, Boyd JR, Eggesbø LM, Lindeman I, Heath JL, Park E, Witte ON, Smale ST, Frietze S, Müschen M.

J Exp Med. 2017 Mar 6;214(3):793-814. doi: 10.1084/jem.20160049. Epub 2017 Feb 11.

9.

Oncogenic epigenetic control.

Stein GS, Messier TL, Gordon JA, Boyd JR, Tye CE, Lian JB, Stein JL.

Aging (Albany NY). 2016 Apr;8(4):565-6. doi: 10.18632/aging.100940. No abstract available.

10.

Oncofetal Epigenetic Bivalency in Breast Cancer Cells: H3K4 and H3K27 Tri-Methylation as a Biomarker for Phenotypic Plasticity.

Messier TL, Boyd JR, Gordon JA, Stein JL, Lian JB, Stein GS.

J Cell Physiol. 2016 Nov;231(11):2474-81. doi: 10.1002/jcp.25359. Epub 2016 Mar 10.

11.

Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes.

Messier TL, Gordon JA, Boyd JR, Tye CE, Browne G, Stein JL, Lian JB, Stein GS.

Oncotarget. 2016 Feb 2;7(5):5094-109. doi: 10.18632/oncotarget.6922.

12.

Expression of Ribosomal RNA and Protein Genes in Human Embryonic Stem Cells Is Associated With the Activating H3K4me3 Histone Mark.

Zaidi SK, Boyd JR, Grandy RA, Medina R, Lian JB, Stein GS, Stein JL.

J Cell Physiol. 2016 Sep;231(9):2007-13. doi: 10.1002/jcp.25309. Epub 2016 Feb 5.

13.

MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells.

Browne G, Dragon JA, Hong D, Messier TL, Gordon JA, Farina NH, Boyd JR, VanOudenhove JJ, Perez AW, Zaidi SK, Stein JL, Stein GS, Lian JB.

Tumour Biol. 2016 Jul;37(7):8825-39. doi: 10.1007/s13277-015-4710-6. Epub 2016 Jan 9.

14.

The psychosocial consequences of pediatric multiple sclerosis.

MacAllister WS, Boyd JR, Holland NJ, Milazzo MC, Krupp LB; International Pediatric MS Study Group.

Neurology. 2007 Apr 17;68(16 Suppl 2):S66-9. Review.

PMID:
17438240
15.

Experiences of children and adolescents living with multiple sclerosis.

Boyd JR, MacMillan LJ.

J Neurosci Nurs. 2005 Dec;37(6):334-42.

PMID:
16396088
16.
17.
18.

A process for delivering bad news: supporting families when a child is diagnosed.

Boyd JR.

J Neurosci Nurs. 2001 Feb;33(1):14-20. Review.

PMID:
11233358
19.
20.

Nonprescription drug screening. Pseudoephedrine.

Boyd JR.

Am Pharm. 1986 Nov;NS26(11):22-4. No abstract available.

PMID:
3799454
21.

On homeopathy: another 'modern-day perspective'.

Boyd JR.

Am Pharm. 1985 Apr;NS25(4):5. No abstract available.

PMID:
4014002
22.

Organization and function of a hospital biomedical engineering internship program.

Peura RA, Boyd JR, Shahnarian A, Driscoll WG, Wheeler HB.

IEEE Trans Biomed Eng. 1975 Mar;22(2):134-40. No abstract available.

PMID:
1123243
23.

Drug defaulting. II. Analysis of noncompliance patterns.

Boyd JR, Covington TR, Stanaszek WF, Coussons RT.

Am J Hosp Pharm. 1974 May;31(5):485-91. No abstract available.

PMID:
4829390
24.

Drug defaulting. I. Determinants of compliance.

Boyd JR, Covington TR, Stanaszek WF, Coussons RT.

Am J Hosp Pharm. 1974 Apr;31(4):362-7. No abstract available.

PMID:
4822025
25.

Identification of ampoules.

Boyd JR, Covington TR.

Lancet. 1973 Feb 10;1(7798):327. No abstract available.

PMID:
4119212
26.

Electroencephalographic recording during progestation treatment.

Ansari AH, Boyd JR, Centa CJ.

Fertil Steril. 1970 Dec;21(12):873-82. No abstract available.

PMID:
5481993
27.

Experiences in assessing fetal acid-base state.

Simonson ED, Schoen JA, Boyd JR.

Am J Obstet Gynecol. 1970 Jul 1;107(5):754-61. No abstract available.

PMID:
4987613
28.

THE CYTOLOGY PROGRAM IN BRITISH COLUMBIA. III. MANAGEMENT OF PRECLINICAL CARCINOMA OF THE CERVIX.

BRYANS FE, BOYES DA, BOYD JR, FIDLER HK.

Can Med Assoc J. 1964 Jan 11;90:62-70.

29.

Conservative management of in situ carcinoma of the cervix.

BOYD JR, ROYLE D, FIDLER HK, BOYES DA.

Am J Obstet Gynecol. 1963 Feb 1;85:322-7. No abstract available.

PMID:
14014689
30.

Occult invasive squamous carcinoma of the cervix.

FIDLER HK, BOYD JR.

Cancer. 1960 Jul-Aug;13:764-71. No abstract available.

PMID:
13822645
31.

A study of eighty cases of cone biopsy of the cervix.

BOYD JR.

Am J Obstet Gynecol. 1958 May;75(5):983-7. No abstract available.

PMID:
13520818
32.

The sequelae of diseases contracted in the Middle East.

BOYD JR.

N Z Med J. 1945 Oct;44:222-30. No abstract available.

PMID:
21004850

Supplemental Content

Support Center